Intratumoral lymphatic vessels: a case of mistaken identity or malfunction?
Jain
Rakesh K
RK
Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, 100 Blossom Street, Cox-7, Boston, MA 02114, USA. jain@steele.mgh.harvard.edu
Fenton
Brenda T
BT
D006023:Glycoproteins / Q000032:analysis / Q000502:physiology; D018398:Homeodomain Proteins / Q000032:analysis / Q000502:physiology; D008207:Lymphatic Metastasis; D008208:Lymphatic System / Q000502:physiology; D020794:Receptor Protein-Tyrosine Kinases / Q000032:analysis / Q000502:physiology; D017978:Receptors, Growth Factor / Q000032:analysis / Q000502:physiology; D025521:Tumor Suppressor Proteins; D040321:Vascular Endothelial Growth Factor Receptor-3; D033921:Vesicular Transport Proteins; D000098551:Prospero-Related Homeobox 1 Protein
D006023:Glycoproteins; D018398:Homeodomain Proteins; C119248:LYVE1 protein, human; D017978:Receptors, Growth Factor; D025521:Tumor Suppressor Proteins; D033921:Vesicular Transport Proteins; D000098551:Prospero-Related Homeobox 1 Protein; D020794:Receptor Protein-Tyrosine Kinases; D040321:Vascular Endothelial Growth Factor Receptor-3